![Lymphadenectomy at the Time of Interval Cytoreduction for Ovarian Cancer with Dimitrios Nasioudis](https://pbcdn1.podbean.com/imglogo/image-logo/16464509/IJGC_300x300.jpg)
Monday Jul 01, 2024
Lymphadenectomy at the Time of Interval Cytoreduction for Ovarian Cancer with Dimitrios Nasioudis
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dimitrios Nasioudis to discuss lymphadenectomy at the time of interval cytoreduction for ovarian cancer. Dimitrios Nasioudis is a gynecologic oncologist at the University of Pennsylvania. Following medical training at the Aristotle University of Thessaloniki, and a research fellowship at the Weill Cornell Medical College he completed his residency and fellowship training at the Hospital of the University of Pennsylvania. His current area of research is translational therapeutics with a focus on low-grade serous ovarian carcinoma. His research interests also include population science and surgical outcomes research.
Highlights:
- The study aimed to evaluate the role of systematic lymphadenectomy during interval cytoreductive surgery in advanced-stage epithelial ovarian carcinoma patients who achieved complete gross resection.
- An analysis of data from 1060 patients found that those who underwent systematic lymphadenectomy had higher rates of unplanned readmissions and longer hospital stays, with no significant difference in overall survival.
- Systematic lymphadenectomy was rarely performed and did not provide a survival benefit for these patients.